Should Minimal Residual Disease Monitoring in Acute Lymphoblastic Leukemia be Standard of Care?

Residual Disease ◽

Lymphoblastic Leukemia ◽

Standard Of Care ◽

Disease Monitoring ◽

Implementation of a simplified flow cytometric assays for minimal residual disease monitoring in childhood acute lymphoblastic leukemia

Cytometry Part B Clinical Cytometry ◽

10.1002/cyto.b.21394 ◽

2016 ◽

Vol 94 (1) ◽

pp. 94-99 ◽

Cited By ~ 4

Author(s):

Ester Vinhas ◽

Norma Lucena-Silva ◽

Francisco Pedrosa

Keyword(s):

Residual Disease ◽

Lymphoblastic Leukemia ◽

Childhood Acute Lymphoblastic Leukemia ◽

Disease Monitoring ◽

Flow Cytometric ◽

Minimal Residual Disease Monitoring By Two Sensitive Techniques May Contribute to Improved Outcome of Allogeneic Transplantation for Ph(-) Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.11.766 ◽

2016 ◽

Vol 22 (3) ◽

pp. S302

Author(s):

Ioanna Sakellari ◽

Apostolia Papalexandri ◽

Vasiliki Douka ◽

Maria Papathanasiou ◽

Konstantina Kotta ◽

...

Keyword(s):

Residual Disease ◽

Lymphoblastic Leukemia ◽

Allogeneic Transplantation ◽

Disease Monitoring ◽

Minimal Residual ◽

Improved Outcome

The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia

Leukemia & Lymphoma ◽

10.3109/10428194.2015.1070153 ◽

2015 ◽

Vol 57 (5) ◽

pp. 1174-1181 ◽

Cited By ~ 6

Author(s):

Wei Wang ◽

Li Gao ◽

Yan Li ◽

Zhen-Ling Li ◽

Ming Gong ◽

...

Keyword(s):

Flow Cytometry ◽

B Cell ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Disease Monitoring ◽

Cell Acute Lymphoblastic Leukemia ◽

An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia

Expert Review of Molecular Diagnostics ◽

10.1080/14737159.2017.1377073 ◽

2017 ◽

Vol 17 (11) ◽

pp. 953-963 ◽

Cited By ~ 6

Author(s):

Vittorio Nunes ◽

Gianni Cazzaniga ◽

A. Biondi

Keyword(s):

Residual Disease ◽

Lymphoblastic Leukemia ◽

Disease Monitoring ◽

Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia

Haematologica ◽

10.3324/haematol.2009.011726 ◽

2009 ◽

Vol 95 (4) ◽

pp. 679-683 ◽

Cited By ~ 18

Author(s):

K. Wilson ◽

M. Case ◽

L. Minto ◽

S. Bailey ◽

N. Bown ◽

...

Keyword(s):

Stem Cells ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Disease Monitoring ◽

Leukemic Stem Cells ◽

B Lineage ◽

Diagnosis of Acute Lymphoblastic Leukemia Originating From T-Lineage Precursors and Approaches to Minimal Residual Disease Monitoring

Clinical oncohematology ◽

10.21320/2500-2139-2019-12-1-79-85 ◽

2018 ◽

Vol 12 (1) ◽

pp. 79-85

Author(s):

OA Chernysheva ◽

◽

LYu Grivtsova ◽

IN Serebryakova ◽

NA Kupryshina ◽

...

Keyword(s):

Residual Disease ◽

Lymphoblastic Leukemia ◽

Disease Monitoring ◽

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring

Leukemia ◽

10.1038/sj.leu.2404047 ◽

2005 ◽

Vol 20 (2) ◽

pp. 254-263 ◽

Cited By ~ 56

Author(s):

L Boublikova ◽

M Kalinova ◽

J Ryan ◽

F Quinn ◽

A O'Marcaigh ◽

...

Keyword(s):

Residual Disease ◽

Wilms Tumor ◽

Lymphoblastic Leukemia ◽

Disease Monitoring ◽

Wide Range ◽

Tumor Gene ◽

Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph‐negative acute lymphoblastic leukemia

European Journal Of Haematology ◽

10.1111/ejh.13268 ◽

2019 ◽

Vol 103 (3) ◽

pp. 164-171 ◽

Cited By ~ 5

Author(s):

Koji Nagafuji ◽

Toshihiro Miyamoto ◽

Tetsuya Eto ◽

Ryosuke Ogawa ◽

Hirokazu Okumura ◽

...

Keyword(s):

Residual Disease ◽

Lymphoblastic Leukemia ◽

Adult Patients ◽

Disease Monitoring ◽

Prospective Evaluation ◽

Minimal residual disease monitoring cannot fully replace bone marrow morphology in assessing disease status in pediatric acute lymphoblastic leukemia

Apmis ◽

10.1111/apm.13037 ◽

2020 ◽

Vol 128 (5) ◽

pp. 414-419

Author(s):

Mathias Rathe ◽

Birgitte Preiss ◽

Hanne Vibeke Marquart ◽

Kjeld Schmiegelow ◽

Peder Skov Wehner

Keyword(s):

Bone Marrow ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Disease Status ◽

Disease Monitoring ◽

Pediatric Acute Lymphoblastic Leukemia ◽

Flow‐cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B‐cell precursor acute lymphoblastic leukemia in trial AIEOP‐BFM‐ALL 2000

Pediatric Blood & Cancer ◽

10.1002/pbc.27590 ◽

2018 ◽

Vol 66 (5) ◽

pp. e27590 ◽

Cited By ~ 3

Author(s):

Angela Schumich ◽

Margarita Maurer‐Granofszky ◽

Andishe Attarbaschi ◽

Ulrike Pötschger ◽

Barbara Buldini ◽

...

Keyword(s):

B Cell ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Disease Monitoring ◽

Cell Precursor ◽

Flow Cytometric ◽